Skip to content
             Company Posts Record Revenue and Earnings Per Share

CHICAGO, Aug. 7 /PRNewswire-FirstCall/ — Allscripts (Nasdaq: MDRX), the
leading provider of clinical software, connectivity and information solutions
that physicians use to improve healthcare, today announced results for the
three and six months ended June 30, 2007.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061005/ALLSCRIPTSLOGO-b)

Total revenue for the three months ended June 30, 2007 was a record
$70.0 million, compared to $60.0 million for the same period last year.
Revenue from software and related services for the three months ended June 30,
2007 was $54.7 million, compared to $46.7 million for the same period last
year, increasing by 17%. Gross margin percentage was 51% for the second
quarter of 2007, compared to 52% during the second quarter of 2006.

Net income for the three months ended June 30, 2007 was $6.0 million, or
$0.10 per diluted share, compared to net income of $2.8 million, or $0.05 per
diluted share, for the same period last year. Non-GAAP adjusted earnings for
the three months ended June 30, 2007 were $7.9 million, or $0.13 per diluted
share — a new record for the Company — compared to non-GAAP adjusted
earnings of $5.1 million, or $0.09 per diluted share for the same period last
year. Non-GAAP adjusted earnings for the three months ended June 30, 2007 and
2006 are comprised of net income giving effect to the add-back of acquisition-
related amortization of $1.5 million and $2.0 million, respectively, or
$0.02 and $0.04 per diluted share, respectively, net of tax, and total
stock-based compensation expense of $0.4 million and $0.3 million,
respectively, or $0.01 and $0.00 per diluted share, respectively, net of tax.
Please see “Explanation of Non-GAAP Financial Measures” below for a discussion
of non-GAAP adjusted earnings and earnings per share.

As of June 30, 2007, the Company had cash and marketable securities of
$87.1 million.

“Allscripts delivered record results in the second quarter and substantial
progress towards our goal of making 2007 our strongest year ever,” said Glen
Tullman, Chief Executive Officer of Allscripts. “Having invested in new
technology and hired aggressively for future growth, we are in position to
capitalize on the significant market opportunity during the second half of the
year, which is traditionally the industry’s strongest sales period. We have a
clear vision for integrating software, connectivity and information to
transform healthcare, and we continue to demonstrate our ability to deliver on
that vision.”

Total revenue for the six months ended June 30, 2007 was $135.1 million,
compared to $102.2 million for the six months ended June 30, 2006. Revenue
from software and related services for the six months ended June 30, 2007 was
$105.9 million, compared to $75.1 million for the same period last year,
increasing by 41%. Gross margin percentage was consistent at 50% for the six
months ended June 30, 2007 and 2006.

Net income for the six months ended June 30, 2007 was $10.5 million, or
$0.18 per diluted share, compared to net income of $4.2 million, or $0.08 per
diluted share, for the same period last year. Non-GAAP adjusted earnings for
the six months ended June 30, 2007 were $14.4 million, or $0.24 per diluted
share, compared to non-GAAP adjusted earnings of $7.5 million, or $0.15 per
diluted share for the same period last year. Non-GAAP adjusted earnings for
the six months ended June 30, 2007 and 2006 are comprised of net income giving
effect to the add-back of acquisition-related amortization of $3.1 million and
$2.9 million, respectively, or $0.05 and $0.06 per diluted share,
respectively, net of tax, and total stock-based compensation expense of
$0.8 million and $0.5 million, respectively, or $0.01 per diluted share for
both reported periods, net of tax.

Allscripts will conduct a conference call on Tuesday, August 7, 2007 at
4:30 PM Eastern Time. The conference call can be accessed by dialing
1-888-644-5594 and requesting the Allscripts earnings call, or via the
Internet at https://www.allscripts.com. A recording of the conference call will
be available for a period of two weeks following the call at
https://www.allscripts.com or by calling 1-800-642-1687, ID # 7223232.

Explanation of Non-GAAP Financial Measures

Allscripts reports its financial results in accordance with generally
accepted accounting principles, or GAAP. To supplement this information,
Allscripts presents in this press release non-GAAP adjusted earnings (and
related per share amounts), which is a non-GAAP financial measure under
Section 101 of Regulation G under the Securities Exchange Act of 1934, as
amended. Non-GAAP adjusted earnings consists of GAAP net income, excluding
acquisition-related amortization and stock-based compensation expense under
SFAS No. 123R, in each case net of any related tax benefit.

    -- Acquisition-Related Amortization.  Acquisition-related amortization
       expense is a non-cash expense arising from the acquisition of
       intangible assets in connection with acquisitions or investments.
       Allscripts excludes acquisition-related amortization expense from
       non-GAAP adjusted earnings because it believes (i) the amount of such
       expenses in any specific period may not directly correlate to the
       underlying performance of Allscripts' business operations and (ii) such
       expenses can vary significantly between periods as a result of new
       acquisitions and full amortization of previously acquired intangible
       assets.  Investors should note that the use of these intangible assets
       contributed to revenue in the periods presented and will contribute to
       future revenue generation and should also note that such expense will
       recur in future periods.

    -- Stock-Based Compensation Expense.  Stock-based compensation expense is
       a non-cash expense arising from the grant of stock awards to employees.
       Allscripts excludes stock-based compensation expense from non-GAAP
       adjusted earnings because it believes (i) the amount of such expenses
       in any specific period may not directly correlate to the underlying
       performance of Allscripts' business operations and (ii) such expenses
       can vary significantly between periods as a result of the timing of
       grants of new stock-based awards, including grants in connection with
       acquisitions.  Investors should note that stock-based compensation is a
       key incentive offered to employees whose efforts contributed to the
       operating results in the periods presented and are expected to
       contribute to operating results in future periods and should also note
       that such expense will recur in future periods.

Management also believes that non-GAAP adjusted earnings (and related per
share amounts) provides useful supplemental information to management and
investors regarding the underlying performance of the Company’s business
operations and facilitates comparisons to our historical operating results.
Management also uses this information internally for forecasting and budgeting
as it believes that the measure is indicative of the Company’s core operating
results. Note however, that non-GAAP adjusted earnings is a performance
measure only, and it does not provide any measure of the Company’s cash flow
or liquidity. Non-GAAP financial measures are not in accordance with, or an
alternative for, measures of financial performance prepared in accordance with
GAAP and may be different from non-GAAP measures used by other companies.
Non-GAAP measures have limitations in that they do not reflect all of the
amounts associated with Allscripts’ results of operations as determined in
accordance with GAAP. Investors and potential investors are encouraged to
review the reconciliation of non-GAAP financial measures with GAAP financial
measures contained within the attached condensed consolidated financial
statements.

About Allscripts

Allscripts is the leading provider of clinical software, connectivity and
information solutions that physicians use to improve healthcare. The Company’s
business units provide unique solutions that inform, connect and transform
healthcare. Allscripts award-winning software applications include Electronic
Health Records, practice management, e-prescribing, document imaging,
emergency department, and care management solutions, all offered through the
Company’s Clinical Solutions units. Additionally, Allscripts provides clinical
product education and connectivity solutions for physicians and patients
through its Physicians Interactive(TM) unit, and medication fulfillment
services through its Medication Services unit. To learn more, visit Allscripts
on the Web at https://www.allscripts.com.

This announcement may contain forward-looking statements about Allscripts
Healthcare Solutions that involve risks and uncertainties. These statements
are developed by combining currently available information with Allscripts
beliefs and assumptions. Forward-looking statements do not guarantee future
performance. Because Allscripts cannot predict all of the risks and
uncertainties that may affect it, or control the ones it does predict,
Allscripts’ actual results may be materially different from the results
expressed in its forward-looking statements. For a more complete discussion of
the risks, uncertainties and assumptions that may affect Allscripts, see the
Company’s 2006 Annual Report on Form 10-K, available through the Web site
maintained by the Securities and Exchange Commission at http://www.sec.gov.



                    Allscripts Healthcare Solutions, Inc.
                    Condensed Consolidated Balance Sheets
                            (amounts in thousands)
                                 (Unaudited)
                                                   June 30,        December 31
    Assets                                           2007              2006

     Current assets:
          Cash and cash equivalents                 $40,376           $42,461
          Marketable securities                      26,992            14,553
          Accounts receivable, net                   69,610            55,579
          Deferred taxes, net                        26,716            27,437
          Inventories                                 4,012             3,247
          Prepaid expenses and other
           current assets                            15,021            10,620
               Total current assets                 182,727           153,897

     Long-term marketable securities                 19,734            26,024
     Fixed assets, net                               17,111            14,094
     Software development costs, net                 18,540            12,285
     Intangible assets, net                          72,927            78,050
     Goodwill                                       184,124           188,261
     Other assets                                     4,308             4,999
               Total assets                        $499,471          $477,610

    Liabilities and Stockholders' Equity

     Current liabilities:
          Accounts payable                          $12,267            $9,294
          Accrued liabilities                        21,701            26,546
          Deferred revenue                           38,613            35,549
          Current portion of long-term debt             268               258
               Total current liabilities             72,849            71,647

     Long-term debt                                  85,304            85,441
     Deferred income taxes                            3,294             3,915
     Other liabilities                                2,022               357
               Total  liabilities                   163,469           161,360

     Stockholders' equity                           336,002           316,250

               Total liabilities and
                stockholders' equity               $499,471          $477,610



                      Allscripts Healthcare Solutions, Inc.
                 Condensed Consolidated Statements of Operations
                 (amounts in thousands, except per-share amounts)
                                   (Unaudited)

                                         Three Months Ended  Six Months Ended
                                              June 30,           June 30,
                                           2007     2006      2007     2006

    Revenue:
          Software and related services   $54,681  $46,745  $105,921  $75,059
          Prepackaged medications          10,939   10,508    21,168   22,018
          Information services              4,421    2,761     7,974    5,141
            Total revenue                  70,041   60,014   135,063  102,218

    Cost of revenue:
          Software and related services    22,797   18,504    45,179   29,985
          Prepackaged medications           9,141    8,716    17,449   18,042
          Information services              2,632    1,522     4,691    2,794
            Total cost of revenue          34,570   28,742    67,319   50,821

    Gross profit                           35,471   31,272    67,744   51,397

    Operating expenses:
          Selling, general and
           administrative expenses         25,425   23,122    47,799   39,930
          Amortization of intangibles       2,576    3,281     5,152    4,651
            Income from operations          7,470    4,869    14,793    6,816

    Interest expense                         (930)    (940)   (1,863)  (1,835)
    Interest income and other, net          1,106      631     2,143    1,712
    Gain on sale of equity investment       2,392       --     2,392       --
    Income before income taxes             10,038    4,560    17,465    6,693

    Income taxes                           (4,010)  (1,733)   (6,970)  (2,543)
    Net income                             $6,028   $2,827   $10,495   $4,150

    Net income per share - basic            $0.11    $0.05     $0.19    $0.09

    Net income per share - diluted          $0.10    $0.05     $0.18    $0.08

    Weighted average shares of common
     stock outstanding used in computing
     basic net income per share            55,648   52,202    55,146   48,573

    Weighted average shares of common
     stock outstanding used in computing
     diluted net income per share          64,802   55,282    64,327   51,665



                         Allscripts Healthcare Solutions, Inc.
          Reconciliation of Non-GAAP Adjusted Earnings and Non-GAAP Adjusted
                                  Earnings Per Share
                   (amounts in thousands, except per-share amounts)
                                      (Unaudited)

                                         Three Months Ended  Six Months Ended
                                               June 30,          June 30,
                                            2007     2006      2007     2006

         Net Income                        $6,028   $2,827   $10,495   $4,150

         Acquisition-Related Amortization
          (tax effected at 38% for 2006
          and 40% for 2007)                 1,546    2,034     3,091    2,884
         Stock-Based Compensation Expense
          (tax effected at 38% for 2006
          and 40% for 2007)                   374      258       767      510


         Non-GAAP Adjusted Earnings        $7,948   $5,119   $14,353   $7,544

         Weighted average shares of
          common stock outstanding used
          in computing diluted non-GAAP
          adjusted earnings per share      64,802   55,282    64,327   51,665

         Non-GAAP Adjusted Earnings per
          share - diluted                   $0.13    $0.09     $0.24    $0.15
SOURCE  Allscripts Healthcare Solutions, Inc.
    -0-                             08/07/2007
    /CONTACT:  Dan Michelson, Chief Marketing Officer, +1-312-506-1217,
dan.michelson@allscripts.com, or Todd Stein, Senior Manager-Public Relations,
+1-312-506-1216, todd.stein@allscripts.com, or Bill Davis, Chief Financial
Officer, +1-312-506-1211, bill.davis@allscripts.com, all of Allscripts
Healthcare Solutions, Inc./
    /Photo:  http://www.newscom.com/cgi-bin/prnh/20061005/ALLSCRIPTSLOGO-b
             AP Archive:  http://photoarchive.ap.org
             PRN Photo Desk, photodesk@prnewswire.com/
    /Web site:  https://www.allscripts.com /
    (MDRX)

CO:  Allscripts Healthcare Solutions, Inc.
ST:  Illinois
IN:  CPR HEA STW
SU:  ERN CCA

RM-AE
-- AQTU208 --
2619 08/07/2007 16:00 EDT http://www.prnewswire.com
Scroll To Top